Open Access. Powered by Scholars. Published by Universities.®

Medicine and Health Sciences Commons

Open Access. Powered by Scholars. Published by Universities.®

University of Wollongong

2016

Treatment

Articles 1 - 4 of 4

Full-Text Articles in Medicine and Health Sciences

Neurodevelopmental Expression Profile Of Dimeric And Monomeric Group 1 Mglurs: Relevance To Schizophrenia Pathogenesis And Treatment, Jeremy Lum, Francesca Fernandez-Enright, Natalie Matosin, Jessica L. Andrews, Xu-Feng Huang, Lezanne Ooi, Kelly A. Newell Jan 2016

Neurodevelopmental Expression Profile Of Dimeric And Monomeric Group 1 Mglurs: Relevance To Schizophrenia Pathogenesis And Treatment, Jeremy Lum, Francesca Fernandez-Enright, Natalie Matosin, Jessica L. Andrews, Xu-Feng Huang, Lezanne Ooi, Kelly A. Newell

Illawarra Health and Medical Research Institute

Group 1 metabotropic glutamate receptors (mGluR1/mGluR5) play an integral role in neurodevelopment and are implicated in psychiatric disorders, such as schizophrenia. mGluR1 and mGluR5 are expressed as homodimers, which is important for their functionality and pharmacology. We examined the protein expression of dimeric and monomeric mGluR1α and mGluR5 in the prefrontal cortex (PFC) and hippocampus throughout development (juvenile/adolescence/adulthood) and in the perinatal phencyclidine (PCP) model of schizophrenia. Under control conditions, mGluR1α dimer expression increased between juvenile and adolescence (209-328%), while monomeric levels remained consistent. Dimeric mGluR5 was steadily expressed across all time points; monomeric mGluR5 was present in juveniles, dramatically …


Reconceptualizing Involuntary Outpatient Psychiatric Treatment From "Capacity" To "Capability", Edwina M. Light, Michael D. Robertson, Ian Kerridge, Philip Boyce, Terry Carney, Alan Rosen, Michelle Cleary, Glenn E. Hunt, Nick O'Connor Jan 2016

Reconceptualizing Involuntary Outpatient Psychiatric Treatment From "Capacity" To "Capability", Edwina M. Light, Michael D. Robertson, Ian Kerridge, Philip Boyce, Terry Carney, Alan Rosen, Michelle Cleary, Glenn E. Hunt, Nick O'Connor

Illawarra Health and Medical Research Institute

Justifying involuntary psychiatric treatment on the basis of a judgment that a person lacks capacity is controversial because there are questions about the meaning and utility of the concept in this context. There are complexities to using capacity in this way, which are further amplified in the community outpatient setting compared with acute inpatient care. A richer account of capacity, its meanings, and practical applications in context, is required. This qualitative study sought to build inductively a model of capacity in the context of involuntary outpatient psychiatric treatment, based on 38 interviews with stakeholders from New South Wales, Australia. The …


Early Antipsychotic Treatment In Juvenile Rats Elicits Long-Term Alterations To The Dopamine Neurotransmitter System, Michael De Santis, Jiamei Lian, Xu-Feng Huang, Chao Deng Jan 2016

Early Antipsychotic Treatment In Juvenile Rats Elicits Long-Term Alterations To The Dopamine Neurotransmitter System, Michael De Santis, Jiamei Lian, Xu-Feng Huang, Chao Deng

Illawarra Health and Medical Research Institute

Prescription of antipsychotic drugs (APDs) to children has substantially increased in recent years. Whilst current investigations into potential long-term effects have uncovered some alterations to adult behaviours, further investigations into potential changes to neurotransmitter systems are required. The current study investigated potential long-term changes to the adult dopamine (DA) system following aripiprazole, olanzapine and risperidone treatment in female and male juvenile rats. Levels of tyrosine hydroxylase (TH), phosphorylated-TH (p-TH), dopamine active transporter (DAT), and D1 and D2 receptors were measured via Western blot and/or receptor autoradiography. Aripiprazole decreased TH and D1 receptor levels in the ventral tegmental …


Development And Feasibility Testing Of Prompt-Care, An Ehealth System For Collection And Use Of Patient-Reported Outcome Measures For Personalized Treatment And Care: A Study Protocol, Afaf Girgis, Geoff P. Delaney, Anthony Arnold, Andrew Alexis Miller, Janelle V. Levesque, Nasreen Kaadan, Martin G. Carolan, Nicole Cook, Kenneth Masters, Thomas T. Tran, Tiffany Sandell, Ivana Durcinoska, Martha Gerges, Sandra Avery, Weng Ng, Stephen Della-Fiorentina, Haryana M. Dhillon, Ashley M. Maher Jan 2016

Development And Feasibility Testing Of Prompt-Care, An Ehealth System For Collection And Use Of Patient-Reported Outcome Measures For Personalized Treatment And Care: A Study Protocol, Afaf Girgis, Geoff P. Delaney, Anthony Arnold, Andrew Alexis Miller, Janelle V. Levesque, Nasreen Kaadan, Martin G. Carolan, Nicole Cook, Kenneth Masters, Thomas T. Tran, Tiffany Sandell, Ivana Durcinoska, Martha Gerges, Sandra Avery, Weng Ng, Stephen Della-Fiorentina, Haryana M. Dhillon, Ashley M. Maher

Illawarra Health and Medical Research Institute

Background: Patient-reported outcome (PRO) measures have been used widely to screen for depression, anxiety, and symptoms in cancer patients. Computer-based applications that collect patients' responses and transfer them to the treating health professional in real time have the potential to improve patient well-being and cancer outcomes.

Objective: This study will test the feasibility and acceptability of a newly developed eHealth system which facilitates PRO data capture from cancer patients, data linkage and retrieval to support clinical decisions and patient self-management, and data retrieval to support ongoing evaluation and innovative research.

Methods: The eHealth system is being developed in consultation with …